| |
| |
|
| Insider
Information: |
Harrington Michael J |
| Relationship: |
|
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
125,394 |
|
|
Indirect Shares
|
59,952 |
|
|
| Direct
Value |
$36,181,413 |
|
|
|
Indirect Value
|
$44,062,921 |
|
|
| Total
Shares |
185,346 |
|
|
| Total
Value |
$80,244,334 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Senior VP and General ... |
2019-10-24 |
47,800 |
2019-10-24 |
59,952 |
Premium* |
|
|
Elanco Animal Health Inc |
ELAN |
|
2024-03-08 |
77,594 |
2019-04-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2024-03-08 |
4 |
B |
$16.29 |
$50,494 |
D/D |
3,100 |
77,594 |
0.01 |
% |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,374 |
74,494 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
54,120 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
35,471 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2021-11-30 |
4 |
B |
$29.25 |
$73,123 |
D/D |
2,500 |
28,164 |
2.39 |
% |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2021-08-11 |
4 |
B |
$28.99 |
$86,955 |
D/D |
3,000 |
25,684 |
2.39 |
% |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
22,684 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2020-03-09 |
4 |
B |
$23.84 |
$95,360 |
D/D |
4,000 |
16,799 |
2.39 |
% |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,496 |
12,779 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-10-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
59,500 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-06-03 |
4 |
AS |
$116.72 |
$1,867,520 |
D/D |
(16,000) |
110,300 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2019-04-22 |
4 |
B |
$26.75 |
$93,608 |
D/D |
3,500 |
6,283 |
2.39 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
62,500 |
47,800 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
62,500 |
62,500 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-04 |
4/A |
A |
$120.17 |
$3,383,507 |
D/D |
28,156 |
126,300 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-04 |
4 |
A |
$120.17 |
$3,383,386 |
D/D |
28,155 |
126,299 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-01 |
4 |
D |
$119.86 |
$527,863 |
D/D |
(4,404) |
98,144 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,778 |
102,548 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2018-02-01 |
4 |
D |
$81.45 |
$880,556 |
D/D |
(10,811) |
91,927 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,524 |
102,738 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2018-01-29 |
4 |
A |
$87.60 |
$1,415,441 |
D/D |
16,158 |
78,214 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2017-06-09 |
4 |
AS |
$79.97 |
$1,825,955 |
D/D |
(22,833) |
62,056 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$349,947 |
D/D |
(4,543) |
84,889 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
89,432 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
